Researchers in Taiwan have developed a new targeted therapy drug that preclinical trials suggest could inhibit the growth of tumors in nearly 30 percent of cancer patients.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
U.S. dollar down in Taipei trading
05/20/2025 10:12 AM - Society
Taiwan headline news
05/20/2025 10:12 AM - Business
Taiwan shares open higher
05/20/2025 09:13 AM - Society
- Society
Taiwanese water expert reflects on work in post-earthquake Myanmar
05/19/2025 10:00 PM